2026-03-06T16:13:15-06:00 2025-04-30 410746749 CLIFTONLARSONALLEN LLP 8215 GREENWAY BOULEVARD SUITE 600 MIDDLETON WI 53562 990 2024-05-01 203502241 MINNEAPOLIS RADIOLOGY AND VASCULAR RESEARCH FOUNDATION MINN 7633982208 2955 XENIUM LANE N 40 PLYMOUTH MN 55441 JOAN STONE CFO 7633982208 2026-03-05 1 1 LAURA SCHWEITZER CPA P01760010 6086628600 2026-03-03 2024 2025-03-06 01:10:19Z JOAN STONE 2955 XENIUM LANE N 40 PLYMOUTH MN 55441 526554 0 X N/A X 2005 MN CONDUCT & RESEARCH DIAGNOSTIC APPROACHES TREATING VASCULAR DISEASE & ADVANCE DIAGNOSTIC IMAGING. 3 1 0 1 0 0 97700 105000 394544 405537 12680 16017 20 0 504944 526554 0 781 0 0 88024 103198 0 0 0 373497 331117 461521 435096 43423 91458 451966 543424 0 0 451966 543424 X THE MINNEAPOLIS RADIOLOGY AND VASCULAR RESEARCH FOUNDATION'S PURPOSES ARE CHARITABLE, SCIENTIFIC AND EDUCATIONAL; PRIMARILY TO CONDUCT AND SUPPORT RESEARCH INTO DIAGNOSTIC, INTERVENTIONAL AND SURGICAL APPROACHES FOR THE TREATMENT OF VASCULAR DISEASE AND FUTURE ADVANCES IN DIAGNOSTIC IMAGING. THE FOUNDATION ALSO PROVIDES GRANTS TO FELLOWS TO ATTEND AND PARTICIPATE IN THE CONFERENCE. 0 0 400720 781 403753 MEDICAL EDUCATION - CONDUCTED 17TH VASCULAR AND ENDOVASCULAR SURGERY CONFERENCE IN 2025. UNLIKE OTHER VASCULAR MEETINGS AND COURSES, OUR CONFERENCE: 1) ADDRESSED THE RAPID GROWTH AND TECHNOLOGICAL INNOVATION FROM THE PERSPECTIVE OF THE PRACTICING VASCULAR SPECIALIST, 2) PROVIDED UP-TO-DATE AND EFFICIENT REVIEWS OF VASCULAR PRACTICE CORE AREAS, 3) PITFALLS ASSOCIATED WITH NEWER PROCEDURES, AND 4) ADDRESSED CRITICAL PRACTICE MANAGEMENT CHANGES AND OPPORTUNITIES ASSOCIATED WITH NEW TECHNOLOGIES. ATTENDEES ACTIVELY PARTICIPATED IN DISCUSSION, HANDS-ON SIMULATOR WORKSHOPS, AND OFFER ONE ANOTHER INSIGHT AND INFORMATION SURROUNDING THE COVERED TOPICS. 3880 1784 MEDICAL RESEARCH STUDIES - PARTICIPATE IN NUMEROUS CLINICAL STUDIES TO ADVANCE INTERVENTIONAL AND SURGICAL PROCEDURES FOR THE TREATMENT OF VASCULAR DISEASE 404600 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 25 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 1 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 1 0 0 0 MN X JOAN STONE 7633982208 2955 XENIUM LANE N STE 40 PLYMOUTH MN 55441 SCHULTZ SCOTT MD PRESIDENT 3.00 X X 9300 0 0 MCMILLAN WILLIAM MD VICE PRESIDENT - SECRETARY 2.00 X X 4800 0 0 WICKLUND DAVID MD TREASURER 0.25 X X 0 0 0 STONE JOAN CFO 10.00 X 20824 0 0 34924 0 0 0 0 0 0 0 105000 105000 EDUCATION PARTICIPANT 900099 344000 344000 REGISTRANT FEES 621500 59753 59753 CLINICAL STUDIES 621500 1784 1784 405537 16017 16017 526554 405537 0 16017 781 781 41554 41554 61644 61644 2783 2783 21593 21593 26903 26903 28 28 19053 19053 109951 109951 144289 144289 810 810 CLINICAL STUDIES EXPENS 3880 3880 OTHER FOUNDATION EXPENS 1802 1802 MN ANNUAL FEE 25 25 435096 404600 30496 0 451966 529811 0 13613 451966 543424 0 0 X 451966 543424 0 0 0 0 451966 543424 451966 543424 91458 0 X 0 0 0 X 106500 97500 97700 105000 406700 15339 302701 345903 394544 405537 1464024 15339 409201 443403 492244 510537 1870724 0 5000 199000 212000 181461 236978 834439 5000 199000 212000 181461 236978 834439 1036285 12680 16017 28697 12680 16017 28697 168 20 188 15339 409201 443571 504944 526554 1899609 0.54550 0.57780 0.01510 0.00710 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS REVENUE - 2022 AMOUNT: $ 168. 2023 AMOUNT: $ 20. 2024 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION A, LINE 8B THE FOUNDATION DOES NOT HAVE ANY COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY THE FOUNDATION'S PUBLIC ACCOUNTING FIRM BASED ON DATA PROVIDED BY MANAGEMENT. ONCE A DRAFT OF THE FILING IS AVAILABLE, THE FORM 990 IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE POLICY REQUIRES ANY INDIVIDUAL WITH AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST TO DISCLOSE THE NATURE OF THE CONFLICT TO THE BOARD OR RELEVANT COMMITTEE BEFORE A TRANSACTION IS CONSIDERED. THE INTERESTED PERSON MAY PRESENT INFORMATION BUT MUST LEAVE THE MEETING DURING DISCUSSION AND VOTING. THE BOARD OR COMMITTEE REVIEWS COMPARABLE DATA, MAY APPOINT DISINTERESTED PARTIES TO EXPLORE ALTERNATIVES, AND DETERMINES WHETHER A CONFLICT-FREE, MORE ADVANTAGEOUS OPTION IS REASONABLY AVAILABLE. IF NOT, THE DISINTERESTED DIRECTORS DECIDE BY MAJORITY VOTE WHETHER THE TRANSACTION IS FAIR, REASONABLE, AND IN THE ORGANIZATION'S BEST INTEREST. FAILURES TO DISCLOSE ARE INVESTIGATED, THE INDIVIDUAL IS GIVEN AN OPPORTUNITY TO RESPOND, AND APPROPRIATE CORRECTIVE OR DISCIPLINARY ACTION IS TAKEN, WITH ALL DISCLOSURES, DISCUSSIONS, ALTERNATIVES, AND VOTES DOCUMENTED IN THE OFFICIAL MINUTES. DISCUSSION AND RESOLUTIONS ARE DOCUMENTED IN THE MEETING MINUTES. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.